doi:10.48130/git-0025-0020

[1]

Yuan J, Ofengeim D. 2024. A guide to cell death pathways. Nature Reviews Molecular Cell Biology 25:379−395

doi: 10.1038/s41580-023-00689-6

[2]

Levine B, Kroemer G. 2019. Biological functions of autophagy genes: a disease perspective. Cell 176:11−42

doi: 10.1016/j.cell.2018.09.048

[3]

Kayagaki N, Kornfeld OS, Lee BL, Stowe IB, O'Rourke K, et al. 2021. NINJ1 mediates plasma membrane rupture during lytic cell death. Nature 591:131−136

doi: 10.1038/s41586-021-03218-7

[4]

Rogers C, Erkes DA, Nardone A, Aplin AE, Fernandes-Alnemri T, et al. 2019. Gasdermin pores permeabilize mitochondria to augment caspase-3 activation during apoptosis and inflammasome activation. Nature Communications 10:1689

doi: 10.1038/s41467-019-09397-2

[5]

Vandenabeele P, Galluzzi L, Vanden Berghe T, Kroemer G. 2010. Molecular mechanisms of necroptosis: an ordered cellular explosion. Nature Reviews Molecular Cell Biology 11:700−714

doi: 10.1038/nrm2970

[6]

Dixon SJ, Lemberg KM, Lamprecht MR, Skouta R, Zaitsev EM, et al. 2012. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell 149:1060−1072

doi: 10.1016/j.cell.2012.03.042

[7]

Tsvetkov P, Coy S, Petrova B, Dreishpoon M, Verma A, et al. 2022. Copper induces cell death by targeting lipoylated TCA cycle proteins. Science 375:1254−1261

doi: 10.1126/science.abf0529

[8]

Guan WL, He Y, Xu RH. 2023. Gastric cancer treatment: recent progress and future perspectives. Journal of Hematology & Oncology 16:57

doi: 10.1186/s13045-023-01451-3

[9]

Ganesh K. 2022. Optimizing immunotherapy for colorectal cancer. Nature Reviews Gastroenterology & Hepatology 19:93−94

doi: 10.1038/s41575-021-00569-4

[10]

Shoji Y, Koyanagi K, Kanamori K, Tajima K, Ogimi M, et al. 2024. Immunotherapy for esophageal cancer: where are we now and where can we go. World Journal of Gastroenterology 30:2496−2501

doi: 10.3748/wjg.v30.i19.2496

[11]

Chong X, Madeti Y, Cai J, Li W, Cong L, et al. 2024. Recent developments in immunotherapy for gastrointestinal tract cancers. Journal of Hematology & Oncology 17:65

doi: 10.1186/s13045-024-01578-x

[12]

Tay C, Tanaka A, Sakaguchi S. 2023. Tumor-infiltrating regulatory T cells as targets of cancer immunotherapy. Cancer Cell 41:450−465

doi: 10.1016/j.ccell.2023.02.014

[13]

Chen Y, Kim J, Yang S, Wang H, Wu CJ, et al. 2021. Type I collagen deletion in αSMA⁺ myofibroblasts augments immune suppression and accelerates progression of pancreatic cancer. Cancer Cell 39:548−565.e6

doi: 10.1016/j.ccell.2021.02.007

[14]

Laskowski TJ, Biederstädt A, Rezvani K. 2022. Natural killer cells in antitumour adoptive cell immunotherapy. Nature Reviews Cancer 22:557−575

doi: 10.1038/s41568-022-00491-0

[15]

Pauken KE, Sammons MA, Odorizzi PM, Manne S, Godec J, et al. 2016. Epigenetic stability of exhausted T cells limits durability of reinvigoration by PD-1 blockade. Science 354:1160−1165

doi: 10.1126/science.aaf2807

[16]

Polishchuk EV, Concilli M, Iacobacci S, Chesi G, Pastore N, et al. 2014. Wilson disease protein ATP7B utilizes lysosomal exocytosis to maintain copper homeostasis. Developmental Cell 29:686−700

doi: 10.1016/j.devcel.2014.04.033

[17]

Mancias JD, Wang X, Gygi SP, Harper JW, Kimmelman AC. 2014. Quantitative proteomics identifies NCOA4 as the cargo receptor mediating ferritinophagy. Nature 509:105−109

doi: 10.1038/nature13148

[18]

Samare-Najaf M, Neisy A, Samareh A, Moghadam D, Jamali N, et al. 2023. The constructive and destructive impact of autophagy on both genders' reproducibility, a comprehensive review. Autophagy 19:3033−3061

doi: 10.1080/15548627.2023.2238577

[19]

Wei F, Wang Y, Yao J, Mei L, Huang X, et al. 2024. ZDHHC7-mediated S-palmitoylation of ATG16L1 facilitates LC3 lipidation and autophagosome formation. Autophagy 20:2719−2737

doi: 10.1080/15548627.2024.2386915

[20]

Diao J, Liu R, Rong Y, Zhao M, Zhang J, et al. 2015. ATG14 promotes membrane tethering and fusion of autophagosomes to endolysosomes. Nature 520:563−566

doi: 10.1038/nature14147

[21]

Festa BP, Siddiqi FH, Jimenez-Sanchez M, Won H, Rob M, et al. 2023. Microglial-to-neuronal CCR5 signaling regulates autophagy in neurodegeneration. Neuron 111:2021−2037.e12

doi: 10.1016/j.neuron.2023.04.006

[22]

Zhu X, Wu Y, Li Y, Zhou X, Watzlawik JO, et al. 2024. The nutrient-sensing Rag-GTPase complex in B cells controls humoral immunity via TFEB/TFE3-dependent mitochondrial fitness. Nature Communications 15:10163

doi: 10.1038/s41467-024-54344-5

[23]

Kim J, Guan KL. 2019. mTOR as a central hub of nutrient signalling and cell growth. Nature Cell Biology 21:63−71

doi: 10.1038/s41556-018-0205-1

[24]

Zhang H, Ge G, Zhang W, Sun H, Liang X, et al. 2024. PP2Ac regulates autophagy via mediating mTORC1 and ULK1 during osteoclastogenesis in the subchondral bone of osteoarthritis. Advanced Science 11:e2404080

doi: 10.1002/advs.202404080

[25]

Wang X, Jia J. 2023. Magnolol improves Alzheimer's disease-like pathologies and cognitive decline by promoting autophagy through activation of the AMPK/mTOR/ULK1 pathway. Biomedicine & Pharmacotherapy 161:114473

doi: 10.1016/j.biopha.2023.114473

[26]

Egan DF, Shackelford DB, Mihaylova MM, Gelino S, Kohnz RA, et al. 2011. Phosphorylation of ULK1 (hATG1) by AMP-activated protein kinase connects energy sensing to mitophagy. Science 331:456−461

doi: 10.1126/science.1196371

[27]

Boukhalfa A, Nascimbeni AC, Ramel D, Dupont N, Hirsch E, et al. 2020. PI3KC2α-dependent and VPS34-independent generation of PI3P controls primary cilium-mediated autophagy in response to shear stress. Nature Communications 11:294

doi: 10.1038/s41467-019-14086-1

[28]

Zorov DB, Juhaszova M, Sollott SJ. 2014. Mitochondrial reactive oxygen species (ROS) and ROS-induced ROS release. Physiological Reviews 94:909−950

doi: 10.1152/physrev.00026.2013

[29]

Komatsu M, Kurokawa H, Waguri S, Taguchi K, Kobayashi A, et al. 2010. The selective autophagy substrate p62 activates the stress responsive transcription factor Nrf2 through inactivation of Keap1. Nature Cell Biology 12:213−223

doi: 10.1038/ncb2021

[30]

Zhang H, Bosch-Marce M, Shimoda LA, Tan YS, Baek JH, et al. 2023. Withdrawal: mitochondrial autophagy is an HIF-1-dependent adaptive metabolic response to hypoxia. Journal of Biological Chemistry 299:105125

doi: 10.1016/j.jbc.2023.105125

[31]

Li X, Wang S, Yu X, Li S. 2023. Transcriptional regulation of autophagy by chromatin remodeling complex and histone variant. Autophagy 19:2824−2826

doi: 10.1080/15548627.2023.2200352

[32]

Ghislat G, Lawrence T. 2018. Autophagy in dendritic cells. Cellular & Molecular Immunology 15:944−952

doi: 10.1038/cmi.2018.2

[33]

Ding L, Guo H, Zhang J, Zheng M, Zhang W, et al. 2024. Zosuquidar promotes antitumor immunity by inducing autophagic degradation of PD-L1. Advanced Science 11:e2400340

doi: 10.1002/advs.202400340

[34]

Shi X, Wu W, Feng Z, Fan P, Shi R, et al. 2023. MARCH7-mediated ubiquitination decreases the solubility of ATG14 to inhibit autophagy. Cell Reports 42:113045

doi: 10.1016/j.celrep.2023.113045

[35]

Hao B, Lin S, Liu H, Xu J, Chen L, et al. 2025. Baicalein tethers CD274/PD-L1 for autophagic degradation to boost antitumor immunity. Autophagy 21:917−933

doi: 10.1080/15548627.2024.2439657

[36]

Levy JM, Thompson JC, Griesinger AM, Amani V, Donson AM, et al. 2014. Autophagy inhibition improves chemosensitivity in BRAF(V600E) brain tumors. Cancer Discovery 4:773−780

doi: 10.1158/2159-8290.CD-14-0049

[37]

Galluzzi L, Guilbaud E, Schmidt D, Kroemer G, Marincola FM. 2024. Targeting immunogenic cell stress and death for cancer therapy. Nature Reviews Drug Discovery 23:445−460

doi: 10.1038/s41573-024-00920-9

[38]

Yu Z, Guo J, Hu M, Gao Y, Huang L. 2020. Icaritin exacerbates mitophagy and synergizes with doxorubicin to induce immunogenic cell death in hepatocellular carcinoma. ACS Nano 14:4816−4828

doi: 10.1021/acsnano.0c00708

[39]

Yamamoto K, Venida A, Yano J, Biancur DE, Kakiuchi M, et al. 2020. Autophagy promotes immune evasion of pancreatic cancer by degrading MHC-I. Nature 581:100−105

doi: 10.1038/s41586-020-2229-5

[40]

Angelin A, Gil-de-Gómez L, Dahiya S, Jiao J, Guo L, et al. 2017. Foxp3 reprograms T cell metabolism to function in low-glucose, high-lactate environments. Cell Metabolism 25:1282−1293.e7

doi: 10.1016/j.cmet.2016.12.018

[41]

Choi Y, Bowman JW, Jung JU. 2018. Autophagy during viral infection − a double-edged sword. Nature Reviews Microbiology 16:341−354

doi: 10.1038/s41579-018-0003-6

[42]

Wei J, Long L, Yang K, Guy C, Shrestha S, et al. 2016. Autophagy enforces functional integrity of regulatory T cells by coupling environmental cues and metabolic homeostasis. Nature Immunology 17:277−285

doi: 10.1038/ni.3365

[43]

Kuo WT, Chang JM, Chen CC, Tsao N, Chang CP. 2022. Autophagy drives plasticity and functional polarization of tumor-associated macrophages. IUBMB Life 74:157−169

doi: 10.1002/iub.2543

[44]

Rangwala R, Chang YC, Hu J, Algazy KM, Evans TL, et al. 2014. Combined MTOR and autophagy inhibition: phase I trial of hydroxychloroquine and temsirolimus in patients with advanced solid tumors and melanoma. Autophagy 10:1391−1402

doi: 10.4161/auto.29119

[45]

Li W, Zhou C, Yu L, Hou Z, Liu H, et al. 2024. Tumor-derived lactate promotes resistance to bevacizumab treatment by facilitating autophagy enhancer protein RUBCNL expression through histone H3 lysine 18 lactylation (H3K18la) in colorectal cancer. Autophagy 20:114−130

doi: 10.1080/15548627.2023.2249762

[46]

Lee MJ, Park JS, Jo SB, Joe YA. 2023. Enhancing anti-cancer therapy with selective autophagy inhibitors by targeting protective autophagy. Biomolecules & Therapeutics 31:1−15

doi: 10.4062/biomolther.2022.153

[47]

Yang WS, Stockwell BR. 2016. Ferroptosis: death by lipid peroxidation. Trends in Cell Biology 26:165−176

doi: 10.1016/j.tcb.2015.10.014

[48]

Zhou Q, Meng Y, Li D, Yao L, Le J, et al. 2024. Ferroptosis in cancer: from molecular mechanisms to therapeutic strategies. Signal Transduction and Targeted Therapy 9:55

doi: 10.1038/s41392-024-01769-5

[49]

Kagan VE, Mao G, Qu F, Angeli JPE, Doll S, et al. 2017. Oxidized arachidonic and adrenic PEs navigate cells to ferroptosis. Nature Chemical Biology 13:81−90

doi: 10.1038/nchembio.2238

[50]

Co HKC, Wu CC, Lee YC, Chen SH. 2024. Emergence of large-scale cell death through ferroptotic trigger waves. Nature 631:654−662

doi: 10.1038/s41586-024-07623-6

[51]

Liu J, Liu M, Zhang H, Wei X, Wang J, et al. 2019. Exploring cysteine regulation in cancer cell survival with a highly specific 'Lock and Key' fluorescent probe for cysteine. Chemical Science 10:10065−10071

doi: 10.1039/C9SC02618E

[52]

Yang WS, SriRamaratnam R, Welsch ME, Shimada K, Skouta R, et al. 2014. Regulation of ferroptotic cancer cell death by GPX4. Cell 156:317−331

doi: 10.1016/j.cell.2013.12.010

[53]

Saraswati S, Marrow SMW, Watch LA, Young PP. 2019. Identification of a pro-angiogenic functional role for FSP1-positive fibroblast subtype in wound healing. Nature Communications 10:3027

doi: 10.1038/s41467-019-10965-9

[54]

Liu Y, Su Z, Tavana O, Gu W. 2024. Understanding the complexity of p53 in a new era of tumor suppression. Cancer Cell 42:946−967

doi: 10.1016/j.ccell.2024.04.009

[55]

Wang Y, Yang L, Zhang X, Cui W, Liu Y, et al. 2019. Epigenetic regulation of ferroptosis by H2B monoubiquitination and p53. EMBO Reports 20:EMBR201847563

doi: 10.15252/embr.201847563

[56]

Wang X, Zhou Y, Min J, Wang F. 2023. Zooming in and out of ferroptosis in human disease. Frontiers of Medicine 17:173−206

doi: 10.1007/s11684-023-0992-z

[57]

Gu Y, Wu S, Fan J, Meng Z, Gao G, et al. 2024. CYLD regulates cell ferroptosis through Hippo/YAP signaling in prostate cancer progression. Cell Death & Disease 15:79

doi: 10.1038/s41419-024-06464-5

[58]

Sun LL, Linghu DL, Hung MC. 2021. Ferroptosis: a promising target for cancer immunotherapy. American Journal of Cancer Research 11:5856−5863

[59]

Wang J, Wang R, Li Y, Huang J, Liu Y, et al. 2024. Lipolysis engages CD36 to promote ZBP1-mediated necroptosis-impairing lung regeneration in COPD. Cell Reports Medicine 5:101732

doi: 10.1016/j.xcrm.2024.101732

[60]

Doll S, Proneth B, Tyurina YY, Panzilius E, Kobayashi S, et al. 2017. ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition. Nature Chemical Biology 13:91−98

doi: 10.1038/nchembio.2239

[61]

Conche C, Finkelmeier F, Pešić M, Nicolas AM, Böttger TW, et al. 2023. Combining ferroptosis induction with MDSC blockade renders primary tumours and metastases in liver sensitive to immune checkpoint blockade. Gut 72:1774−1782

doi: 10.1136/gutjnl-2022-327909

[62]

Yin LB, Li ZW, Wang JL, Wang L, Hou L, et al. 2023. Sulfasalazine inhibits esophageal cancer cell proliferation by mediating ferroptosis. Chemical Biology & Drug Design 102:730−737

doi: 10.1111/cbdd.14281

[63]

Wen Z, Sun H, Zhang Z, Zheng Y, Zheng S, et al. 2023. High baseline tumor burden-associated macrophages promote an immunosuppressive microenvironment and reduce the efficacy of immune checkpoint inhibitors through the IGFBP2-STAT3-PD-L1 pathway. Cancer Communications 43:562−581

doi: 10.1002/cac2.12420

[64]

Ronan B, Flamand O, Vescovi L, Dureuil C, Durand L, et al. 2014. A highly potent and selective Vps34 inhibitor alters vesicle trafficking and autophagy. Nature Chemical Biology 10:1013−1019

doi: 10.1038/nchembio.1681

[65]

Li Y, Cheng X. 2024. Enhancing colorectal cancer immunotherapy: the pivotal role of ferroptosis in modulating the tumor microenvironment. International Journal of Molecular Sciences 25:9141

doi: 10.3390/ijms25179141

[66]

Cao W, Zhang X, Feng Y, Li R, Lu A, et al. 2024. Lipid nanoparticular codelivery system for enhanced antitumor effects by ferroptosis-apoptosis synergistic with programmed cell death-ligand 1 downregulation. ACS Nano 18:17267−17281

doi: 10.1021/acsnano.4c04901

[67]

Ma X, Mao M, He J, Liang C, Xie HY. 2023. Nanoprobe-based molecular imaging for tumor stratification. Chemical Society Reviews 52:6447−6496

doi: 10.1039/D3CS00063J

[68]

Chen W, Lu Y, Sun X, Leng J, Lin S, et al. 2024. A multifunctional CaCO₃ bioreactor coated with coordination polymers enhances cancer immunotherapy. Journal of Controlled Release 368:780−796

doi: 10.1016/j.jconrel.2024.03.026

[69]

Yan H, Talty R, Aladelokun O, Bosenberg M, Johnson CH. 2023. Ferroptosis in colorectal cancer: a future target? British Journal of Cancer 128:1439−1451

doi: 10.1038/s41416-023-02149-6

[70]

Zheng Y, Sun L, Guo J, Ma J. 2023. The crosstalk between ferroptosis and anti-tumor immunity in the tumor microenvironment: molecular mechanisms and therapeutic controversy. Cancer Communications 43:1071−1096

doi: 10.1002/cac2.12487

[71]

Chen L, Min J, Wang F. 2022. Copper homeostasis and cuproptosis in health and disease. Signal Transduction and Targeted Therapy 7:378

doi: 10.1038/s41392-022-01229-y

[72]

Tang D, Chen X, Kroemer G. 2022. Cuproptosis: a copper-triggered modality of mitochondrial cell death. Cell Research 32:417−418

doi: 10.1038/s41422-022-00653-7

[73]

Kim BE, Nevitt T, Thiele DJ. 2008. Mechanisms for copper acquisition, distribution and regulation. Nature Chemical Biology 4:176−185

doi: 10.1038/nchembio.72

[74]

Xiong C, Ling H, Hao Q, Zhou X. 2023. Cuproptosis: p53-regulated metabolic cell death? Cell Death & Differentiation 30:876−884

doi: 10.1038/s41418-023-01125-0

[75]

Du M, Fu J, Zhang J, Zhu Z, Huang X, et al. 2024. CircSpna2 attenuates cuproptosis by mediating ubiquitin ligase Keap1 to regulate the Nrf2-Atp7b signalling axis in depression after traumatic brain injury in a mouse model. Clinical and Translational Medicine 14:e70100

doi: 10.1002/ctm2.70100

[76]

Liao Q, Deng J, Tong J, Gan Y, Hong W, et al. 2025. p53 induces circFRMD4A to suppress cancer development through glycolytic reprogramming and cuproptosis. Molecular Cell 85:132−149.e7

doi: 10.1016/j.molcel.2024.11.013

[77]

Li C, Song J, Guo Z, Gong Y, Zhang T, et al. 2022. EZH2 inhibitors suppress colorectal cancer by regulating macrophage polarization in the tumor microenvironment. Frontiers in Immunology 13:857808

doi: 10.3389/fimmu.2022.857808

[78]

Lei G, Zhuang L, Gan B. 2022. Targeting ferroptosis as a vulnerability in cancer. Nature Reviews Cancer 22:381−396

doi: 10.1038/s41568-022-00459-0

[79]

Benjamin DI, Brett JO, Both P, Benjamin JS, Ishak HL, et al. 2023. Multiomics reveals glutathione metabolism as a driver of bimodality during stem cell aging. Cell Metabolism 35:472−486.e6

doi: 10.1016/j.cmet.2023.02.001

[80]

Hakimi AA, Reznik E, Lee CH, Creighton CJ, Brannon AR, et al. 2016. An Integrated metabolic atlas of clear cell renal cell carcinoma. Cancer Cell 29:104−116

doi: 10.1016/j.ccell.2015.12.004

[81]

Wang Y, Zhang L, Zhou F. 2022. Cuproptosis: a new form of programmed cell death. Cellular & Molecular Immunology 19:867−868

doi: 10.1038/s41423-022-00866-1

[82]

Xie Q, Sun T, Zhang L, Gong M, Zhang W, et al. 2025. Responsive plasmonic hybrid nanorods enables metabolism reprogramming via cuproptosis-photothermal combined cancer therapy. Biomaterials 315:122971

doi: 10.1016/j.biomaterials.2024.122971

[83]

Xu X, Xie T, Zhou M, Sun Y, Wang F, et al. 2024. Hsc70 promotes anti-tumor immunity by targeting PD-L1 for lysosomal degradation. Nature Communications 15:4237

doi: 10.1038/s41467-024-48597-3

[84]

Zhang X, Wang J, Wang G, Zhang Y, Fan Q, et al. 2025. First-line sugemalimab plus chemotherapy for advanced gastric cancer: the GEMSTONE-303 randomized clinical trial. JAMA 333:1305−1314

doi: 10.1001/jama.2024.28463

[85]

Wu L, Bai R, Zhang Y, Chen H, Wu J, et al. 2024. METTL3-VISTA axis-based combination immunotherapy for APC truncation colorectal cancer. Journal for Immunotherapy of Cancer 12:e009865

doi: 10.1136/jitc-2024-009865

[86]

Yan C, Liu Y, Zhao G, Yang H, Lv H, et al. 2024. Inhalable metal-organic framework-mediated cuproptosis combined with PD-L1 checkpoint blockade for lung metastasis synergistic immunotherapy. Acta Pharmaceutica Sinica B 14:2281−2297

doi: 10.1016/j.apsb.2024.01.017

[87]

Zhu G, Xie Y, Wang J, Wang M, Qian Y, et al. 2024. Multifunctional copper-phenolic nanopills achieve comprehensive polyamines depletion to provoke enhanced pyroptosis and cuproptosis for cancer immunotherapy. Advanced Materials 36:e2409066

doi: 10.1002/adma.202409066

[88]

Lu X, Chen X, Lin C, Yi Y, Zhao S, et al. 2024. Elesclomol loaded copper oxide nanoplatform triggers cuproptosis to enhance antitumor immunotherapy. Advanced Science 11:e2309984

doi: 10.1002/advs.202309984

[89]

Chen K, Zhou A, Zhou X, He J, Xu Y, et al. 2024. Cellular Trojan Horse initiates bimetallic Fe-Cu MOF-mediated synergistic cuproptosis and ferroptosis against malignancies. Science Advances 10:eadk3201

doi: 10.1126/sciadv.adk3201